A drug in the Platform might belong to different modalities, including small molecules, antibodies or oligonucleotides among others. However, some biologic therapies such as vaccines, blood products or cell therapies are not represented in our drug set. Moreover, the molecule-centric definition implies multi-ingredient drugs won't be represented and only their individual active moieties might be available on the site.